Skye Bioscience, Inc. (SKYE)
0.7773
-0.04
(-5.13%)
USD |
NASDAQ |
Feb 09, 16:00
0.7638
-0.01
(-1.74%)
After-Hours: 20:00
Skye Bioscience EPS Diluted (Quarterly) : -0.3216 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Eli Lilly & Co. | 7.390 |
| Theravance Biopharma, Inc. | 0.0696 |
| Viking Therapeutics, Inc. | -0.8083 |
| Kyntra Bio, Inc. | 36.71 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.75M |
| Total Expenses (Quarterly) | 12.75M |
| Enterprise Value | -10.07M |
| Earnings Yield | -165.9% |
| Normalized Earnings Yield | -169.73 |